Strategies for early detection of chronic Q-fever: A systematic review

European Journal of Clinical Investigation

Volumn 43, Issue 6, 2013, Pages 616-639

  Wielders, Cornelia C H ^a,b   Morroy, Gabriëlla ^c,d   Wever, Peter C ^b   Coutinho, Roel A ^a,e   Schneeberger, Peter M ^a,b   van der Hoek, Wim ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c Municipal Health Service Hart voor Brabant   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coxiella burnetii; Follow up studies; Outbreak; Q fever; Screening; Serology

Indexed keywords

BACTERIUM ANTIBODY;

ARTICLE; ASYMPTOMATIC INFECTION; BACTERIUM DETECTION; CHRONIC DISEASE; COXIELLA BURNETII; ECHOCARDIOGRAPHY; EMBASE; FOLLOW UP; HEART INJURY; HIGH RISK PATIENT; HUMAN; MEDLINE; PRIORITY JOURNAL; Q FEVER; SCREENING; SEROLOGY; SYSTEMATIC REVIEW; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

DISEASE OUTBREAKS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ENDEMIC DISEASES; FOLLOW-UP STUDIES; HUMANS; Q FEVER; RISK FACTORS; SEROLOGIC TESTS;

EID: 84877714076     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12073     Document Type: Article

References (45)

1. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999;12:518-53.
2. Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005;5:219-26.
3. European Centre for Disease Prevention and Control. Risk Assessment on Q Fever. Stockholm: ECDC, 2010; Available at: http://ecdc.europa.eu/en/publications/Publications/1005_TER_Risk_Assessment_Qfever.pdf. Accessed on 3 August 2012.
4. Tissot-Dupont H, Raoult D. Q fever. Infect Dis Clin North Am 2008;22:505-14, ix.
5. Botelho-Nevers E, Fournier PE, Richet H, Fenollar F, Lepidi H, Foucault C, et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis 2007;26:635-40.
6. Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010;10:527-35.
7. Landais C, Fenollar F, Thuny F, Raoult D. From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis 2007;44:1337-40.
8. Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 2007;44:232-7.
9. Tissot-Dupont H, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol 1994;1:189-96.
10. Fournier PE, Casalta JP, Piquet P, Tournigand P, Branchereau A, Raoult D. Coxiella burnetii infection of aneurysms or vascular grafts: report of seven cases and review. Clin Infect Dis 1998;26:116-21.
11. Wegdam-Blans MC, Wielders CC, Meekelenkamp J, Korbeeck JM, Herremans T, Tjhie HT, et al. Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera. Clin Vaccine Immunol 2012;19:1110-5.
12. Hung MN, Lin LJ, Hou MY, Lin PS, Wang YC, Shu PY, et al. Serologic assessment of the risk of developing chronic Q fever in cohorts of acutely infected individuals. J Infect 2011;62:39-44.
13. Limonard GJ, Nabuurs-Franssen MH, Weers-Pothoff G, Wijkmans C, Besselink R, Horrevorts AM, et al. One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection 2010;38:471-7.
14. Reilly S, Northwood JL, Caul EO. Q fever in Plymouth, 1972-88. A review with particular reference to neurological manifestations. Epidemiol Infect 1990;105:391-408.
15. van der Hoek W, Versteeg B, Meekelenkamp JC, Renders NH, Leenders AC, Weers-Pothoff I, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 2011;52:1431-6.
16. Wagner-Wiening C, Brockmann S, Kimmig P. Serological diagnosis and follow-up of asymptomatic and acute Q fever infections. Int J Med Microbiol 2006;296(Suppl 40):294-6.
17. Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83:574-9.
18. Fenollar F, Thuny F, Xeridat B, Lepidi H, Raoult D. Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin Infect Dis 2006;42:818-21.
19. Kampschreur LM, Hagenaars JC, Wielders CC, Elsman P, Lestrade PJ, Koning OH, et al. Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect 2013;141:847-51.
20. Kampschreur LM, Oosterheert JJ, Hoepelman AI, Lestrade PJ, Renders NH, Elsman P, et al. Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii Is epidemic. Clin Vaccine Immunol 2012;19:1165-9.
21. Wegdam-Blans MC, Stokmans RA, Tjhie JH, Korbeeck JM, Koopmans MP, Evers SM, et al. Targeted screening as a tool for the early detection of chronic Q fever patients after a large outbreak. Eur J Clin Microbiol Infect Dis 2013;32:353-9.
22. Fervers B, Remy-Stockinger M, Mazeau-Woynar V, Otter R, Liberati A, Littlejohns P, et al. CoCanCPG. Coordination of cancer clinical practice in Europe. Tumori 2008;94:154-9.
23. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839-42.
24. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2008. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed on 17 October 2012.
25. Hussain-Yusuf H, Islam A, Healy B, Lockhart M, Nguyen C, Sukocheva O, et al. An analysis of Q fever patients 6 years after an outbreak in Newport, Wales, UK. QJM 2012;105:1067-73.
26. Ayres JG, Wildman M, Groves J, Ment J, Smith EG, Beattie JM. Long-term follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue. QJM 2002;95:539-46.
27. Kováčová E, Kazár J, Šimková A. Clinical and serological analysis of a Q fever outbreak in western Slovakia with four-year follow-up. Eur J Clin Microbiol Infect Dis 1998;17:867-9.
28. Lovey PY, Morabia A, Bleed D, Peter O, Dupuis G, Petite J. Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study. BMJ 1999;319:284-6.
29. Marmion BP, Storm PA, Ayres JG, Semendric L, Mathews L, Winslow W, et al. Long-term persistence of Coxiella burnetii after acute primary Q fever. QJM 2005;98:7-20.
30. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001;33:312-6.
31. Hartzell JD, Gleeson T, Scoville S, Massung RF, Wortmann G, Martin GJ. Practice guidelines for the diagnosis and management of patients with Q fever by the Armed Forces Infectious Diseases Society. Mil Med 2012;177:484-94.
32. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1, 383 infections. Medicine (Baltimore) 2000;79:109-23.
33. Soriano F, Camacho MT, Ponte C, Gomez P. Serological differentiation between acute (late control) and endocarditis Q fever. J Clin Pathol 1993;46:411-4.
34. Wegdam-Blans MC, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, et al. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect 2012;64:247-59.
35. Wilson JM, Jungner G. Principles and Practice of Screening for Disease, Vol. 34. Geneva: World Health Organization Public Health Papers, 1968. Available at: http://whqlibdoc.who.int/php/WHO_PHP_34.pdf. Accessed on 22 November 2012.
36. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007;45:548-55.
37. Nielsen SY, Hjollund NH, Andersen AM, Henriksen TB, Kantso B, Krogfelt KA, et al. Presence of antibodies against Coxiella burnetii and risk of spontaneous abortion: a nested case-control study. PLoS ONE 2012;7:e31909.
38. Munster JM. Q Fever During Pregnancy. Lessons from the Dutch Epidemic [Dissertation]. Groningen: University of Groningen, 2012, Available at: http://dissertations.ub.rug.nl/faculties/medicine/2012/j.m.munster/. Accessed on 1 November 2012.
39. Kampschreur LM, Wever PC, Wegdam-Blans MC, Delsing CE, Bleeker-Rovers CP, Sprong T, et al. Defining chronic Q fever: a matter of debate. J Infect 2012;65:362-3.
40. Raoult D, Chronic Q. fever: expert opinion versus literature analysis and consensus. J Infect 2012;65:102-8.
41. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
42. Palmer SR, Young SE. Q-fever endocarditis in England and Wales, 1975-81. Lancet 1982;2:1448-9.
43. Munster JM, Leenders ACAP, Hamilton CJCM, Meekelenkamp JCE, Schneeberger PM, van der Hoek W et al. Routine screening for Coxiella burnetii infection during pregnancy: a clustered randomised controlled trial. In: Munster JM, editors. Q Fever During Pregnancy. Lessons from the Dutch Epidemic [Dissertation]. Groningen: University of Groningen; 2012, pp 59-78. Available at: http://dissertations.ub.rug.nl/faculties/medicine/2012/j.m.munster/. Accessed on 1 November 2012.
44. van Woerden HC, Mason BW, Nehaul LK, Smith R, Salmon RL, Healy B, et al. Q fever outbreak in industrial setting. Emerg Infect Dis 2004;10:1282-9.
45. Healy B, Llewelyn M, Westmoreland D, Lloyd G, Brown N. The value of follow-up after acute Q fever infection. J Infect 2006;52:e109-12.